Overview

Bioequivalence Study Comparing Arimidex Tablet and Anastrozole ODF in Japanese Healthy Male Subjects

Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This study is to investigate whether anastrozole ODF is bioequivalent with Arimidex tablet after a single oral administration of each anastrozole formulation.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Anastrozole